Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
AGXT and ERCC2 polymorphisms are associated with clinical outcome in metastatic colorectal cancer patients treated with 5-FU/oxaliplatin.
Pharmacogenomics J. 2016 Jun;16(3):272-9. doi: 10.1038/tpj.2015.54. Epub 2015 Aug 11.
Pharmacogenomics J. 2016.
PMID: 26261061
Detection of Recurrent Prostate Cancer With 18F-Fluciclovine PET/MRI.
Selnæs KM, Krüger-Stokke B, Elschot M, Johansen H, Steen PA, Langørgen S, Aksnessæther BY, Indrebø G, Sjøbakk TAE, Tessem MB, Moestue SA, Knobel H, Tandstad T, Bertilsson H, Solberg A, Bathen TF.
Selnæs KM, et al. Among authors: indrebo g.
Front Oncol. 2020 Dec 23;10:582092. doi: 10.3389/fonc.2020.582092. eCollection 2020.
Front Oncol. 2020.
PMID: 33425735
Free PMC article.
Item in Clipboard
Testicular cancer and the tuberous sclerosis complex.
Tandstad T, Indrebø G.
Tandstad T, et al. Among authors: indrebo g.
Acta Oncol. 2012 Feb;51(2):262-5. doi: 10.3109/0284186X.2011.587450. Epub 2011 Jul 18.
Acta Oncol. 2012.
PMID: 21767201
No abstract available.
Item in Clipboard
Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings.
Kubicka S, Greil R, André T, Bennouna J, Sastre J, Van Cutsem E, von Moos R, Osterlund P, Reyes-Rivera I, Müller T, Makrutzki M, Arnold D; ML18147 study investigators including AIO, GERCOR, FFCD, UNICANCER GI, TTD, BGDO, GEMCAD, and AGMT groups.
Kubicka S, et al.
Ann Oncol. 2013 Sep;24(9):2342-9. doi: 10.1093/annonc/mdt231. Epub 2013 Jul 12.
Ann Oncol. 2013.
PMID: 23852309
Free article.
Clinical Trial.
Item in Clipboard
Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial.
Bennouna J, Sastre J, Arnold D, Österlund P, Greil R, Van Cutsem E, von Moos R, Viéitez JM, Bouché O, Borg C, Steffens CC, Alonso-Orduña V, Schlichting C, Reyes-Rivera I, Bendahmane B, André T, Kubicka S; ML18147 Study Investigators.
Bennouna J, et al.
Lancet Oncol. 2013 Jan;14(1):29-37. doi: 10.1016/S1470-2045(12)70477-1. Epub 2012 Nov 16.
Lancet Oncol. 2013.
PMID: 23168366
Clinical Trial.
Item in Clipboard
Cite
Cite